Medindia

X

Titanium Group Announces Biometric Contract with One of the Most Active Clinics in Hong Kong

Wednesday, November 28, 2007 General News J E 4
Advertisement
SAN JOSE, Calif., Nov. 27 Titanium Group, Ltd(OTC Bulletin Board: TTNUF), a leading biometric and security solutionsprovider announced today it has signed a contract with Hong Kong PolytechnicUniversity Clinic for the installation of a biometric pharmacy system poweredby Titanium's Biometric Facial Recognition technology. In this newly designedapplication, all patients, together with their corresponding medical histories,are registered into the system. After each visit, the patients would then berequired to verify their identities before collecting their medication,ensuring that everyone will be taking the correct drugs prescribed by thephysicians.

"Given there have been cases in other clinics where patients took thewrong drug leading to very serious problems, this system is designedspecifically for the clinic to avoid any potential occurrence of such a nature,and thus liability, for the clinic. This use of Titanium's Biometric FacialRecognition technologies is a ground-breaking application of our products andwe are excited to see our technologies working effectively, now in thehealthcare industry. This is a very large and growing sector which is full ofmarket potential for our products in the region," said Billy Tang, COO ofTitanium Group Ltd.

The Clinic provides primary health care services, nursing practices,dispensary and laboratory services, health education and promotion, and TCMservice. Over 20,000 full time students, staff and their dependents, as wellas retirees on the campus of approximately 93,500 square meters are covered bythis service.

About Titanium Group:

Titanium Group, Ltd (http://www.titanium-tech.com), and its wholly ownedsubsidiary Titanium Technology, is a leading biometric and security solutionsprovider featuring its proprietary and patented automated Face RecognitionSystems (AFRS). Titanium's AFRS products capture human face imageselectronically, input the facial images into searchable files (faceprint) and,in just seconds, accurately compare the facial images to a database containingmillions of faces. These cutting-edge products reduce administration cost,enhance security, and significantly increase overall productivity. Titanium'sproducts are distributed worldwide, either directly or through resellers orOEM partners, to governments, law enforcement agencies, gaming companies, andother organizations. The Company's clients include: ESPN, IBM and the PeoplesBank of China.

Safe Harbor Provisions

Certain oral statements made by management from time to time and certainstatements contained in press releases and periodic reports issued by TitaniumGroup, Ltd. (the "Company"), as well as those contained herein, that are nothistorical facts are "forward-looking statements" within the meaning ofSection 21E of the Securities and Exchange Act of 1934 and, because suchstatements involve risks and uncertainties, actual results may differmaterially from those expressed or implied by such forward-looking statements.Forward-looking statements, including those in Management's Discussion andAnalysis, are statements regarding the intent, belief or current expectations,estimates or projections of the Company, its Directors or its Officers aboutthe Company and the industry in which it operates, and are based onassumptions made by management. Forward looking statements include withoutlimitation statements regarding: (a) the Company's strategies regarding growthand business expansion, including future acquisitions; (b) the Company'sfinancing plans; (c) trends affecting the Company's financial condition orresults of operations; (d) the Company's ability to continue to control costsand to meet its liquidity and other financing needs; (e) the declaration andpayment of dividends; and (f) the Company's ability to respond to changes incustomer demand and regulations. Although the Company believes that itsexpecta
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Singulex Teams With Wyeth Pharmaceuticals to Trans...
S
Emageon Signs Multi-year Cardiovascular PACS Agree...